Lihi Atzmony1,2,3, Nelson Ugwu1, Theodore D Zaki1, Richard J Antaya1, Keith A Choate1,2,4. 1. Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA. 2. Department of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA. 3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 4. Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
Abstract
BACKGROUND: Congenital smooth muscle hamartomas (CSMHs) are benign lesions that share clinical and histopathological features with Becker nevus, a mosaic disorder associated with post-zygotic ACTB mutations. Given the clinical and histopathological overlap between CSMH and Becker nevus, we hypothesized that post-zygotic mutations in ACTB may underlie CSMH. METHODS: Direct sequencing of ACTB gene in affected and unaffected tissue isolated from one case of hemihypertrichosis and hemihypertrophy corresponding to giant segmental CSMH and hemihypertrophy. This was followed by direct sequencing with and without enrichment assay for hotspot ACTB mutations in affected tissue from 12 samples of isolated CSMH from unrelated individuals. RESULTS: In total we identified somatic missense ACTB mutations in 9 out of 13 CSMHs (69%). Mutations were either novel or previously reported in Becker nevi and Becker nevus syndrome. CONCLUSIONS: CSMHs result from post-zygotic ACTB mutations. This study proves that CSMHs and Becker nevi are nosologically related, and expand the phenotypic spectrum of ACTB mutations.
BACKGROUND:Congenital smooth muscle hamartomas (CSMHs) are benign lesions that share clinical and histopathological features with Becker nevus, a mosaic disorder associated with post-zygotic ACTB mutations. Given the clinical and histopathological overlap between CSMH and Becker nevus, we hypothesized that post-zygotic mutations in ACTB may underlie CSMH. METHODS: Direct sequencing of ACTB gene in affected and unaffected tissue isolated from one case of hemihypertrichosis and hemihypertrophy corresponding to giant segmental CSMH and hemihypertrophy. This was followed by direct sequencing with and without enrichment assay for hotspot ACTB mutations in affected tissue from 12 samples of isolated CSMH from unrelated individuals. RESULTS: In total we identified somatic missense ACTB mutations in 9 out of 13 CSMHs (69%). Mutations were either novel or previously reported in Becker nevi and Becker nevus syndrome. CONCLUSIONS: CSMHs result from post-zygotic ACTB mutations. This study proves that CSMHs and Becker nevi are nosologically related, and expand the phenotypic spectrum of ACTB mutations.
Authors: Alireza Zarineh; Milena E Kozovska; William G Brown; David E Elder; Michael S Rabkin Journal: J Cutan Pathol Date: 2008-06-09 Impact factor: 1.587
Authors: Jennifer J Johnston; Kuo-Kuang Wen; Kim Keppler-Noreuil; Melissa McKane; Jessica L Maiers; Alexander Greiner; Julie C Sapp; Kris A Demali; Peter A Rubenstein; Leslie G Biesecker Journal: Hum Mutat Date: 2013-05-28 Impact factor: 4.878
Authors: Sara Cuvertino; Helen M Stuart; Kate E Chandler; Neil A Roberts; Ruth Armstrong; Laura Bernardini; Sanjeev Bhaskar; Bert Callewaert; Jill Clayton-Smith; Cristina Hernando Davalillo; Charu Deshpande; Koenraad Devriendt; Maria C Digilio; Abhijit Dixit; Matthew Edwards; Jan M Friedman; Antonio Gonzalez-Meneses; Shelagh Joss; Bronwyn Kerr; Anne Katrin Lampe; Sylvie Langlois; Rachel Lennon; Philippe Loget; David Y T Ma; Ruth McGowan; Maryse Des Medt; James O'Sullivan; Sylvie Odent; Michael J Parker; Céline Pebrel-Richard; Florence Petit; Zornitza Stark; Sylvia Stockler-Ipsiroglu; Sigrid Tinschert; Pradeep Vasudevan; Olaya Villa; Susan M White; Farah R Zahir; Adrian S Woolf; Siddharth Banka Journal: Am J Hum Genet Date: 2017-12-07 Impact factor: 11.025